BX Swiss TOP 30 CHF
1.261,10
PKT
+8,37
PKT
+0,67
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.11.16 | Holcim buy | Deutsche Bank AG | |
| 07.11.16 | Holcim Neutral | JP Morgan Chase & Co. | |
| 07.11.16 | Richemont buy | Deutsche Bank AG | |
| 07.11.16 | UBS buy | Citigroup Corp. | |
| 07.11.16 | Holcim Sell | Société Générale Group S.A. (SG) | |
| 07.11.16 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 07.11.16 | Swiss Re Underweight | Morgan Stanley | |
| 07.11.16 | Holcim Outperform | BNP PARIBAS | |
| 07.11.16 | Zurich Insurance buy | Baader Wertpapierhandelsbank | |
| 07.11.16 | UBS buy | HSBC | |
| 04.11.16 | Roche overweight | Morgan Stanley | |
| 04.11.16 | Holcim Hold | S&P Capital IQ | |
| 04.11.16 | Roche buy | Goldman Sachs Group Inc. | |
| 04.11.16 | UBS Underweight | JP Morgan Chase & Co. | |
| 04.11.16 | UBS neutral | Macquarie Research | |
| 04.11.16 | UBS buy | Citigroup Corp. | |
| 04.11.16 | UBS buy | UBS AG | |
| 03.11.16 | Swiss Re kaufen | DZ BANK | |
| 03.11.16 | UBS Sell | S&P Capital IQ | |
| 03.11.16 | Swiss Re buy | S&P Capital IQ | |
| 03.11.16 | Roche buy | Citigroup Corp. | |
| 03.11.16 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 03.11.16 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.11.16 | UBS Buy | Deutsche Bank AG | |
| 02.11.16 | UBS Hold | Commerzbank AG | |
| 02.11.16 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 02.11.16 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.11.16 | Richemont Hold | Société Générale Group S.A. (SG) | |
| 31.10.16 | UBS Underweight | JP Morgan Chase & Co. | |
| 31.10.16 | Novartis buy | Baader Wertpapierhandelsbank | |
| 28.10.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 28.10.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 27.10.16 | ABB (Asea Brown Boveri) Sell | S&P Capital IQ | |
| 27.10.16 | UBS Hold | Commerzbank AG | |
| 26.10.16 | Holcim buy | Deutsche Bank AG | |
| 26.10.16 | Novartis Outperform | Credit Suisse Group | |
| 26.10.16 | Novartis Hold | Deutsche Bank AG | |
| 26.10.16 | Zurich Insurance Hold | Deutsche Bank AG | |
| 26.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 25.10.16 | UBS overweight | Barclays Capital |